What is Sign.UseWise™ for Microsoft 365?
Sign.UseWise™ is a cloud-based email signature management application built for Microsoft 365. It empowers organizations to centrally manage and deploy consistent, professional email signatures across all users, ensuring unified brand identity and unlocking promotional opportunities with every email sent.
How to get started with Sign.UseWise™ application?
Sign.UseWise™ app is available on both Microsoft AppSource and Azure marketplace for installation. zure and Microsoft AppSource Marketplace. To get started with Sign.UseWise™ app, go to https://usewise.app//sign-usewise-microsoft-365 and select your marketplace from where you want to purchase the app – Microsoft Azure or AppSource marketplace. It is important to note that you need to be a Microsoft global administrator to be able to install the app for your company.
Can I try Sign.UseWise™ app before buying it?
There is a one-month free trial period to test the Sign.UseWise™ application for free. Free trials automatically convert to a paid subscription at the end of the trial, unless you decide to cancel the subscription before the trial period ends.
Do I need to install any software on my users’ computers?
No, Sign.UseWise™ is a cloud-based service, so there’s no need for local software installations. All management is done through a web-based admin portal by a Microsoft 365 global administrator.
How do I create and design email signatures in Sign.UseWise™ app?
Sign.UseWise™ app provides a user-friendly WYSIWYG signature editor with lots of functionalities, allowing you to easily create and customize professional signatures with logos, images, QR codes, banners and dynamic data fields.
Can I use dynamic data fields in my signatures, like user names and departments?
Yes, Sign.UseWise™ integrates with your Microsoft 365 directory and enables you to automatically update signature fields with user information like first name, last name, email address, job title, mobile phone number and other information available in your Azure AD.
